FLEXI-Haz: Semiparametric Deep Survival Inference Beyond Proportional Hazards
Organizations: Department of Statistics and Operations Research, Tel Aviv University, Israel
Abstract
Flexible survival prediction does not by itself ensure valid inference for covariate effects or subject-specific survival probabilities. We develop FLEXI-Haz, a semiparametric deep neural network model for right-censored data that combines an interpretable linear component in the log-hazard with a flexible function of time and adjustment covariates. This formulation permits nonproportional nuisance effects while retaining interpretable regression parameters. Under regularity conditions, we establish nuisance convergence rates that are minimax optimal up to logarithmic factors over composite Holder classes, together with root-n-consistent, asymptotically normal, and semiparametrically efficient estimation of the regression parameter. For adjustment covariates with finite support, we derive the explicit influence function for cumulative hazard and construct a cross-fitted one-step estimator yielding asymptotically valid pointwise confidence intervals for subject-specific survival. Simulations demonstrate reduced bias and improved coverage relative to a proportional hazards comparator under time-varying nuisance effects. An analysis of the Rotterdam breast cancer data illustrates the consequences of flexible adjustment for inference on treatment associations.
Figures & tables
| Parameter/Method | Est. | Emp. SD | Est. SE | 90%CI | 95% CI | |||
|---|---|---|---|---|---|---|---|---|
| 1 | 4000 | FLEXI–Haz | 0.404 | 0.026 | 0.024 | 87.5 (82.9, 92.1) | 94.0 (90.7, 97.3) | |
| Zhong et al. | 0.412 | 0.029 | 0.024 | 82.0 (76.7, 87.3) | 90.5 (86.4, 94.6) | |||
| 1 | 4000 | FLEXI–Haz | 0.404 | 0.035 | 0.033 | 88.0 (83.5, 92.5) | 94.5 (91.3, 97.7) | |
| Zhong et al. | 0.393 | 0.034 | 0.033 | 85.5 (80.6, 90.4) | 93.0 (89.5, 96.5) | |||
| 1 | 4000 | FLEXI–Haz | 0.405 | 0.050 | 0.046 | 86.5 (81.8, 91.2) | 95.0 (92.0, 98.0) | |
| Zhong et al. | 0.399 | 0.044 | 0.046 | 91.0 (87.0, 95.0) | 96.0 (93.3, 98.7) |
| Marginal survival | 90% CI | SD | 95% CI | SD | |
|---|---|---|---|---|---|
| 0.1 | 6.7126 | 0.9377 | 0.0741 | 0.9676 | 0.0531 |
| 0.2 | 4.2934 | 0.9120 | 0.0861 | 0.9548 | 0.0638 |
| 0.3 | 3.0192 | 0.9167 | 0.0769 | 0.9565 | 0.0595 |
| 0.4 | 2.2003 | 0.9121 | 0.0755 | 0.9595 | 0.0523 |
| 0.5 | 1.6035 | 0.8903 | 0.0889 | 0.9488 | 0.0589 |
| 0.6 | 1.2330 | 0.8997 | 0.0912 | 0.9520 | 0.0611 |
| Treatment | FLEXI–Haz | Zhong et al. (2022) | Cox PH |
|---|---|---|---|
| Hormonal | |||
| Chemo |
| Treatment | ER | FLEXI–Haz | Zhong et al. (2022) | Cox PH |
|---|---|---|---|---|
| Hormonal | Low | |||
| Hormonal | High | |||
| Chemo | Low | |||
| Chemo | High |
Appendix figures & tables7 assets
Supplementary material from the paper’s appendix.
Appendix
| FLEXI–Haz | Zhong et al. | LR | FLEXI–Haz | Zhong et al. | LR | ||
|---|---|---|---|---|---|---|---|
| 0 | 0 | ||||||
| 0 | 0.5 | ||||||
| 0 | 0.75 | ||||||
| 0.5 | 0 | ||||||
| 0.5 | 0.5 | ||||||
| Component | Parameter | Value |
|---|---|---|
| Main network | Optimizer | Adam |
| Learning rates | ||
| Epoch limit / patience | 500 per phase / 30 | |
| Batch size | ||
| Initializations per replication | 5 | |
| Projection network | Folds | 5, by subject |
| Depth | Width sequences |
|---|---|
| 1 | , , , , |
| 2 | , , , , , , |
| 3 | , , , , , , |
| 4 | , , , , |
| 5 | , , |
| Method | Hidden widths | Learning rate(s) | |
|---|---|---|---|
| 2000 | FLEXI–Haz | ||
| 4000 | FLEXI–Haz | ||
| 8000 | FLEXI–Haz | ||
| 2000 | Zhong et al. | ||
| 4000 | Zhong et al. | ||
| 8000 | Zhong et al. |
| Analysis | Fold | FLEXI–Haz | Zhong et al. | LR |
|---|---|---|---|---|
| Overall effects | 1 | |||
| 2 | ||||
| 3 | ||||
| 4 | ||||
| 5 | ||||
| ER interactions | 1 |
| Variable | Group 1 | Group 2 | Group 3 | Group 4 |
|---|---|---|---|---|
| Age (years) | – | – | ||
| Positive lymph nodes | – | — | ||
| ER | – | – | ||
| PGR | – | — |
| Rank | Age | Meno | Size | Grade | Nodes | PGR | ER | Events | Censored | |
| 1 | Post | 3 | 0 | 46 | 26 | 20 | ||||
| 2 | Pre | 20–50 | 3 | 0 | 38 | 20 | 18 | |||
| 3 | 55–65 | Post | 3 | 0 | 37 | 12 | 25 | |||
| 4 | 55–65 | Post | 3 | 0 | 10–99 | 36 | 9 | 27 | ||
| 5 | Post | 20–50 | 3 | 0 | 36 | 20 | 16 | |||
| 6 | Pre | 3 | 0 | 35 | 16 | 19 |
Survival Analysis
Survival analysis models when events such as disease progression, failure, or death occur, accounting for incomplete follow-up and censoring.
See all 106 papers